A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing ...

Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a new study has uncovered neurological and behavioral health ...